Featured Research

from universities, journals, and other organizations

New tool better estimates pandemic threats

Date:
March 5, 2013
Source:
Public Library of Science
Summary:
A simple new method better assesses the risks posed by emerging zoonotic viruses (those transmissible from animals to humans), according to a new study. Scientists have shown that the new tool can produce transmissibility estimates for swine flu (the H3N2v-M virus), allowing researchers to better evaluate the possible pandemic threat posed by this virus.

A simple new method better assesses the risks posed by emerging zoonotic viruses (those transmissible from animals to humans), according to a study published in PLOS Medicine this week. Dr. Simon Cauchemez and colleagues from Imperial College London in the UK and the Centers for Disease Control and Prevention in the US show that the new tool can produce transmissibility estimates for swine flu (the H3N2v-M virus), allowing researchers to better evaluate the possible pandemic threat posed by this virus. Until now, estimates of transmissibility were derived from detailed outbreak investigations, which are resource intensive and subject to selection bias. In this study, the authors develop a method to derive unbiased estimates of transmissibility with more limited data.

This study has important health policy implications because of the large numbers of people that could potentially be harmed by emerging viruses. Zoonotic viruses primarily cause occasional infections in human populations exposed to reservoir species (the animal species harboring the virus) because the pathogens are usually poorly adapted for sustained human-to-human transmission. However, zoonotic viruses are under strong selective pressure to acquire the ability for human-to-human transmission. Dr. Cauchemez and colleagues show that the novel approach described in this paper will be useful in assessing human-to-human transmissions during zoonotic outbreaks.

The researchers developed a mathematical model of disease transmission, which only requires data from routine surveillance and standard case investigations. They showed that the pandemic potential of a zoonotic virus could be estimated simply from the proportion of cases infected by the natural reservoir. The authors then applied their new approach to assess the human-to-human transmissibility of H1N1v, H1N2v and H3N2v viruses (in particular that of the H3N2v-M virus) from US surveillance data for the period December 2005 to December 2011 and Nipah virus in Malaysia and Bangladesh, as well as to a non-zoonotic pathogen Vibrio cholerae in the Dominican Republic. This study demonstrates the applicability of this novel approach to estimating the reproduction number R (or the number of individuals infected by a case), during zoonotic and certain non-zoonotic outbreaks.

The technique for estimating R described in this paper is simple and robust and does not require as much investigative effort as existing methods, say the authors. However, a key limitation of this new approach is that it is designed to estimate R during subcritical outbreaks. If it is not a subcritical outbreak, other methods are needed to estimate R.

Dr. Lyn Finelli, Surveillance and Outbreak Response Team (Influenza Division, CDC) and co-author on the paper said: "Outbreaks of the H3N2v-M virus largely took place at livestock exhibitions with thousands of visitors every day. It is very hard to perform detailed outbreak investigations and effectively trace cases in such settings since visitors are widely dispersed. The approach presented in the paper, is simple, requires few data, and was very useful in assessing transmissibility of the virus from the data available."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Simon Cauchemez, Scott Epperson, Matthew Biggerstaff, David Swerdlow, Lyn Finelli, Neil M. Ferguson. Using Routine Surveillance Data to Estimate the Epidemic Potential of Emerging Zoonoses: Application to the Emergence of US Swine Origin Influenza A H3N2v Virus. PLoS Medicine, 2013; 10 (3): e1001399 DOI: 10.1371/journal.pmed.1001399

Cite This Page:

Public Library of Science. "New tool better estimates pandemic threats." ScienceDaily. ScienceDaily, 5 March 2013. <www.sciencedaily.com/releases/2013/03/130305174530.htm>.
Public Library of Science. (2013, March 5). New tool better estimates pandemic threats. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/03/130305174530.htm
Public Library of Science. "New tool better estimates pandemic threats." ScienceDaily. www.sciencedaily.com/releases/2013/03/130305174530.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins